Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry
ISSN: 0975-413X
Dipanjan Mandal
Department of Pharmacology, Guru Nanak Institute of Pharmaceutical Science and Technology, Sodepur Kolkata-700114, IndiaPublications
-
Review
ADVANCED DEVELOPMENT ON MARBURG VIRUS AND IT?S VACCINATION: A REVIEW
Author(s): Lopamudra Saha and Dipanjan Mandal*
Marburg Virus (MARV) belongs to the family of animal viruses and is the reason for a deadly and severely troubling viral hemorrhagic fever. The fatality rate of the virus ranges from 24.0 to 88.0%, demonstrating its deadly nature and also the need for its widespread information. The first case of the Marburg virus sickness (MARD) was reported in 1967 when science laboratory personnel operating with African inexperienced monkeys got infected in the Federal Republic of Germany and Belgrade at the same time. Following the initial case, many more outbreaks occurred around the world, such as in Uganda, Angola, Congo, African countries, and even within the United States in 2008. The Egyptian chiropteran (Rousettus aegyptiacus) is thought to be one in every one of the significant sources of infection, and tourists visiting caves inhabited by these haywire or employees accessing mines populat.. Read More»
DOI: 10.4172/0975-413X.15.1.7-12
Select your language of interest to view the total content in your interested language
Google Scholar citation report
Citations : 25868
Der Pharma Chemica received 25868 citations as per Google Scholar report
Der Pharma Chemica peer review process verified at publons
DOWNLOADS
